首页 > 最新文献

Current Diabetes Reports最新文献

英文 中文
A Systematic Review of Interventions for the Transition to Adult Healthcare for Young People with Diabetes. 对青少年糖尿病患者向成人医疗保健过渡的干预措施的系统回顾。
IF 6.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-02-01 DOI: 10.1007/s11892-025-01578-2
Sean DeLacey, Jaclyn Papadakis, Steven James, Laura Cudizio, Sze May Ng, Sarah K Lyons, Nisa M Maruthur, Aleksandra Araszkiewicz, Apoorva Gomber, Frank J Snoek, Eva Toft, Carine de Beaufort, Jill Weissberg-Benchell

Purpose of review: The transition to adult healthcare is difficult for young adults with diabetes, with declining glycemic control and reduced healthcare utilization. Efforts are needed to facilitate an effective transfer of care. Our study aimed to systematically review the literature and identify studies evaluating the effectiveness of interventions designed to improve transition readiness and/or the transfer to adult care, describe their characteristics and outcomes, and identify areas for future research.

Recent findings: Twenty-six studies were included with one randomized control trial and many pre-post studies observing the impact of transition programs. Generally, interventions had no clear benefit on metabolic outcomes, with variable improvement in care satisfaction and transition readiness. Studies often did not satisfy quality metrics, report important contextual factors (e.g. race, ethnicity) or involve family members. The current literature on interventions to improve transition readiness and transfer of care outcomes in young adults with diabetes is relatively limited with few studies applying rigorous methods. Future studies should apply formal methodology, include both medical and psychosocial outcomes and account for patient and health system context.

回顾目的:年轻糖尿病患者很难过渡到成人医疗保健,血糖控制下降,医疗保健利用率降低。需要努力促进有效的护理转移。我们的研究旨在系统地回顾文献并确定评估干预措施有效性的研究,这些干预措施旨在提高过渡准备和/或转移到成人护理,描述其特征和结果,并确定未来研究的领域。最近的发现:26项研究包括一项随机对照试验和许多观察过渡计划影响的前后研究。一般来说,干预措施对代谢结果没有明显的好处,在护理满意度和过渡准备方面有不同的改善。研究通常不满足质量指标,报告重要的背景因素(如种族、民族)或涉及家庭成员。目前关于改善年轻糖尿病患者的过渡准备和护理结果转移的干预措施的文献相对有限,很少有研究采用严格的方法。未来的研究应采用正式的方法,包括医疗和社会心理结果,并考虑患者和卫生系统的情况。
{"title":"A Systematic Review of Interventions for the Transition to Adult Healthcare for Young People with Diabetes.","authors":"Sean DeLacey, Jaclyn Papadakis, Steven James, Laura Cudizio, Sze May Ng, Sarah K Lyons, Nisa M Maruthur, Aleksandra Araszkiewicz, Apoorva Gomber, Frank J Snoek, Eva Toft, Carine de Beaufort, Jill Weissberg-Benchell","doi":"10.1007/s11892-025-01578-2","DOIUrl":"10.1007/s11892-025-01578-2","url":null,"abstract":"<p><strong>Purpose of review: </strong>The transition to adult healthcare is difficult for young adults with diabetes, with declining glycemic control and reduced healthcare utilization. Efforts are needed to facilitate an effective transfer of care. Our study aimed to systematically review the literature and identify studies evaluating the effectiveness of interventions designed to improve transition readiness and/or the transfer to adult care, describe their characteristics and outcomes, and identify areas for future research.</p><p><strong>Recent findings: </strong>Twenty-six studies were included with one randomized control trial and many pre-post studies observing the impact of transition programs. Generally, interventions had no clear benefit on metabolic outcomes, with variable improvement in care satisfaction and transition readiness. Studies often did not satisfy quality metrics, report important contextual factors (e.g. race, ethnicity) or involve family members. The current literature on interventions to improve transition readiness and transfer of care outcomes in young adults with diabetes is relatively limited with few studies applying rigorous methods. Future studies should apply formal methodology, include both medical and psychosocial outcomes and account for patient and health system context.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"25 1","pages":"21"},"PeriodicalIF":6.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12228552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143074173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subtypes of Insulin Restriction in Diabetes Management: A Systematic Review. 糖尿病管理中胰岛素限制的亚型:系统综述。
IF 6.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-27 DOI: 10.1007/s11892-025-01577-3
Aislinn B Beam, Deborah J Wiebe

Purpose of review: Insulin restriction is commonly studied as a form of disordered eating, but people may restrict insulin for many reasons. This systematic review examined how insulin restriction has been conceptualized and measured, and its associated predictors and outcomes.

Recent findings: Forty-seven unique articles measured non-specified insulin restriction (IR), insulin restriction specifically for weight control (IRWC), or both. Eight studies used non-specified measures to examine insulin restriction for a specific purpose. IR was more prevalent than IRWC, but both occurred equally among men and women across ages. Higher negative emotions were associated with both constructs, while lower self-management behaviors were examined and associated only with IR; both constructs were associated with higher HbA1c. When measured simultaneously, IR and IRWC were not correlated. There may be subtypes of insulin restriction. Future research should develop measures to assess and examine distinct subtypes, and translate findings into effective interventions for this dangerous behavior.

综述目的:胰岛素限制通常被研究为饮食失调的一种形式,但人们限制胰岛素的原因有很多。本系统综述研究了胰岛素限制是如何被概念化和测量的,以及其相关的预测因素和结果。最近的发现:47篇独特的文章测量了非特定胰岛素限制(IR),胰岛素限制专门用于控制体重(IRWC),或两者兼而有之。八项研究使用非指定的方法来检查胰岛素限制是否有特定目的。IR比IRWC更普遍,但在不同年龄的男性和女性中发生率相同。较高的负面情绪与两种构念都相关,而较低的自我管理行为仅与IR相关;两种结构都与较高的HbA1c相关。同时测量时,IR和IRWC不相关。胰岛素限制可能有不同的亚型。未来的研究应该制定措施来评估和检查不同的亚型,并将研究结果转化为对这种危险行为的有效干预。
{"title":"Subtypes of Insulin Restriction in Diabetes Management: A Systematic Review.","authors":"Aislinn B Beam, Deborah J Wiebe","doi":"10.1007/s11892-025-01577-3","DOIUrl":"10.1007/s11892-025-01577-3","url":null,"abstract":"<p><strong>Purpose of review: </strong>Insulin restriction is commonly studied as a form of disordered eating, but people may restrict insulin for many reasons. This systematic review examined how insulin restriction has been conceptualized and measured, and its associated predictors and outcomes.</p><p><strong>Recent findings: </strong>Forty-seven unique articles measured non-specified insulin restriction (IR), insulin restriction specifically for weight control (IRWC), or both. Eight studies used non-specified measures to examine insulin restriction for a specific purpose. IR was more prevalent than IRWC, but both occurred equally among men and women across ages. Higher negative emotions were associated with both constructs, while lower self-management behaviors were examined and associated only with IR; both constructs were associated with higher HbA1c. When measured simultaneously, IR and IRWC were not correlated. There may be subtypes of insulin restriction. Future research should develop measures to assess and examine distinct subtypes, and translate findings into effective interventions for this dangerous behavior.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"25 1","pages":"20"},"PeriodicalIF":6.4,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143045855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contextualization of Diabetes: A Review of Reviews from Organisation for Economic Co-operation and Development (OECD) Countries. 糖尿病情境化:经济合作与发展组织(OECD)国家综述。
IF 6.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-24 DOI: 10.1007/s11892-024-01574-y
Sieara Plebon-Huff, Hubi Haji-Mohamed, Helene Gardiner, Samantha Ghanem, Jessica Koh, Allana G LeBlanc

Purpose of review: The prevalence of diabetes is rising around the world and represents an important public health concern. Unlike individual-level risk and protective factors related to the etiology of diabetes, contextual risk factors have been much less studied. Identification of contextual factors related to the risk of type 1 and type 2 diabetes in Organisation for Economic Co-operation and Development (OECD) countries may help health professionals, researchers, and policymakers to improve surveillance, develop policies and programs, and allocate funding.

Recent findings: Among 4,470 potential articles, 48 were included in this review. All reviews were published in English between 2005 and 2023 and were conducted in over 20 different countries. This review identified ten upstream contextual risk factors related to type 1 and type 2 diabetes risk, including income, employment, education, immigration, race/ethnicity, geography, rural/urban status, built environment, environmental pollution, and food security/environment. The ten upstream contextual risk factors identified this review may be integrated into diabetes research, surveillance and prevention activities to help promote better outcomes for people at risk or living with diabetes in OECD countries. Additional research is needed to better quantify the measures of associations between emerging key contextual factors and diabetes outcomes.

综述目的:糖尿病的患病率在世界范围内呈上升趋势,是一个重要的公共卫生问题。不同于与糖尿病病因相关的个人水平的风险和保护因素,环境风险因素的研究要少得多。经济合作与发展组织(OECD)国家中与1型和2型糖尿病风险相关的环境因素的识别可能有助于卫生专业人员、研究人员和决策者改善监测、制定政策和项目以及分配资金。最近的发现:在4470篇潜在的文章中,48篇被纳入本综述。所有的评论都是在2005年至2023年期间用英文发表的,在20多个不同的国家进行。本综述确定了10个与1型和2型糖尿病风险相关的上游背景风险因素,包括收入、就业、教育、移民、种族/民族、地理、农村/城市状况、建筑环境、环境污染和食品安全/环境。本综述确定的10个上游背景风险因素可纳入糖尿病研究、监测和预防活动,以帮助促进经合组织国家糖尿病风险人群或糖尿病患者获得更好的结果。需要进一步的研究来更好地量化新出现的关键背景因素与糖尿病结局之间的关联。
{"title":"Contextualization of Diabetes: A Review of Reviews from Organisation for Economic Co-operation and Development (OECD) Countries.","authors":"Sieara Plebon-Huff, Hubi Haji-Mohamed, Helene Gardiner, Samantha Ghanem, Jessica Koh, Allana G LeBlanc","doi":"10.1007/s11892-024-01574-y","DOIUrl":"10.1007/s11892-024-01574-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>The prevalence of diabetes is rising around the world and represents an important public health concern. Unlike individual-level risk and protective factors related to the etiology of diabetes, contextual risk factors have been much less studied. Identification of contextual factors related to the risk of type 1 and type 2 diabetes in Organisation for Economic Co-operation and Development (OECD) countries may help health professionals, researchers, and policymakers to improve surveillance, develop policies and programs, and allocate funding.</p><p><strong>Recent findings: </strong>Among 4,470 potential articles, 48 were included in this review. All reviews were published in English between 2005 and 2023 and were conducted in over 20 different countries. This review identified ten upstream contextual risk factors related to type 1 and type 2 diabetes risk, including income, employment, education, immigration, race/ethnicity, geography, rural/urban status, built environment, environmental pollution, and food security/environment. The ten upstream contextual risk factors identified this review may be integrated into diabetes research, surveillance and prevention activities to help promote better outcomes for people at risk or living with diabetes in OECD countries. Additional research is needed to better quantify the measures of associations between emerging key contextual factors and diabetes outcomes.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"25 1","pages":"19"},"PeriodicalIF":6.4,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11758158/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143028153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Value of Medical Nutrition Therapy and Diabetes Self-Management Education and Support in Diabetes Care and Education: A Call to Action to Increase Referrals and Recognize Insurance Coverage Variation. 医学营养治疗和糖尿病自我管理教育在糖尿病护理和教育中的价值和支持:呼吁采取行动增加转诊和认识保险覆盖范围的变化。
IF 6.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-23 DOI: 10.1007/s11892-024-01573-z
Amy Hess-Fischl

Purpose of review: Evidence over the past few decades have proven the benefits and cost savings of diabetes self-management education and support (DSMES) and medical nutrition therapy (MNT). Yet, the benefits continue to be underutilized. Little evidence is available to definitively assess insurance coverage for both services. Strategies are presented to more efficiently assess coverage as well as Identify methods to increase referrals and more effectively bill for both services.

Recent findings: Estimated statistics for both type 1 and type 2 diabetes reveal increases globally, especially in those under 20 and over 65. Individuals meeting the current A1C guidelines are still well below current recommendations. The economic costs of diabetes continue to rise. Both DSMES and MNT are effective, cost-saving methods that are critical components to the ongoing care of people with diabetes. While insurance coverage does vary based on each specific type, billing correctly and following the requirements for NSDSMES are essential to receive appropriate reimbursement for services.

回顾目的:过去几十年的证据已经证明糖尿病自我管理教育和支持(DSMES)以及医学营养治疗(MNT)的益处和成本节约。然而,这些好处仍然没有得到充分利用。几乎没有证据可以明确评估这两种服务的保险范围。提出了更有效地评估覆盖面的战略,以及确定增加转诊和更有效地为这两种服务收费的方法。最新发现:1型和2型糖尿病的估计统计数据显示,全球范围内,特别是在20岁以下和65岁以上的人群中,发病率均有所上升。符合当前糖化血红蛋白指南的个体仍远低于当前的推荐值。糖尿病的经济成本持续上升。DSMES和MNT都是有效的、节省成本的方法,是糖尿病患者持续护理的关键组成部分。虽然保险范围确实根据每种特定类型而有所不同,但正确计费并遵循nssdsmes的要求对于获得适当的服务报销至关重要。
{"title":"The Value of Medical Nutrition Therapy and Diabetes Self-Management Education and Support in Diabetes Care and Education: A Call to Action to Increase Referrals and Recognize Insurance Coverage Variation.","authors":"Amy Hess-Fischl","doi":"10.1007/s11892-024-01573-z","DOIUrl":"10.1007/s11892-024-01573-z","url":null,"abstract":"<p><strong>Purpose of review: </strong>Evidence over the past few decades have proven the benefits and cost savings of diabetes self-management education and support (DSMES) and medical nutrition therapy (MNT). Yet, the benefits continue to be underutilized. Little evidence is available to definitively assess insurance coverage for both services. Strategies are presented to more efficiently assess coverage as well as Identify methods to increase referrals and more effectively bill for both services.</p><p><strong>Recent findings: </strong>Estimated statistics for both type 1 and type 2 diabetes reveal increases globally, especially in those under 20 and over 65. Individuals meeting the current A1C guidelines are still well below current recommendations. The economic costs of diabetes continue to rise. Both DSMES and MNT are effective, cost-saving methods that are critical components to the ongoing care of people with diabetes. While insurance coverage does vary based on each specific type, billing correctly and following the requirements for NSDSMES are essential to receive appropriate reimbursement for services.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"25 1","pages":"18"},"PeriodicalIF":6.4,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143022636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing Diabetes Distress in Primary Care: Where Are We Now, and Where Do We Need to Go? 解决初级保健中的糖尿病困扰:我们现在在哪里,我们需要去哪里?
IF 6.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-18 DOI: 10.1007/s11892-025-01576-4
Marisa Kostiuk, E Seth Kramer, Andrea Nederveld, Danielle M Hessler, Lawrence Fisher, Jessica A Parascando, Tamara K Oser

Purpose of review: Addressing diabetes distress (DD), the emotional demands of living with diabetes, is a crucial component of diabetes care. Most individuals with type 2 diabetes and approximately half of adults with type 1 diabetes receive their care in the primary care setting. This review will provide guidance on addressing DD and implementing targeted techniques that can be tailored to primary care patients.

Recent findings: Structured educational, behavioral, and emotion-focused techniques have promise for treating DD. These interventions are unlikely to require advanced training and can be feasibly integrated into primary care settings without creating additional burdens on time or resources. Interventional studies examining treatment for DD are limited, leaving a gap for clear direction and consensus on how to target and treat DD in primary care patients. This review consolidates recommendations and approaches from recent findings on how to treat DD within the context of primary care.

综述目的:解决糖尿病困扰(DD),即糖尿病患者的情感需求,是糖尿病护理的重要组成部分。大多数2型糖尿病患者和大约一半的1型糖尿病成人患者在初级保健机构接受治疗。这篇综述将为解决DD和实施针对初级保健患者的针对性技术提供指导。最近的研究发现:结构化的教育、行为和以情感为中心的技术有望治疗DD。这些干预措施不太可能需要高级培训,可以可行地整合到初级保健环境中,而不会造成额外的时间和资源负担。检查DD治疗的介入性研究是有限的,在如何针对和治疗初级保健患者DD的明确方向和共识上留下了空白。这篇综述整合了最近关于如何在初级保健的背景下治疗DD的建议和方法。
{"title":"Addressing Diabetes Distress in Primary Care: Where Are We Now, and Where Do We Need to Go?","authors":"Marisa Kostiuk, E Seth Kramer, Andrea Nederveld, Danielle M Hessler, Lawrence Fisher, Jessica A Parascando, Tamara K Oser","doi":"10.1007/s11892-025-01576-4","DOIUrl":"10.1007/s11892-025-01576-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>Addressing diabetes distress (DD), the emotional demands of living with diabetes, is a crucial component of diabetes care. Most individuals with type 2 diabetes and approximately half of adults with type 1 diabetes receive their care in the primary care setting. This review will provide guidance on addressing DD and implementing targeted techniques that can be tailored to primary care patients.</p><p><strong>Recent findings: </strong>Structured educational, behavioral, and emotion-focused techniques have promise for treating DD. These interventions are unlikely to require advanced training and can be feasibly integrated into primary care settings without creating additional burdens on time or resources. Interventional studies examining treatment for DD are limited, leaving a gap for clear direction and consensus on how to target and treat DD in primary care patients. This review consolidates recommendations and approaches from recent findings on how to treat DD within the context of primary care.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"25 1","pages":"17"},"PeriodicalIF":6.4,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143001680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of SGLT2 Inhibitors on Lipoproteins in Type 2 Diabetes. SGLT2抑制剂对2型糖尿病脂蛋白的影响
IF 6.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-07 DOI: 10.1007/s11892-024-01572-0
Pablo Corral, Natalia Nardelli, Alicia Elbert, Florencia Aranguren, Laura Schreier

Purpose of review: This article explores the cardiovascular effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes mellitus (T2DM), with a particular focus on their impact on lipid profiles. As evidence grows of the cardiovascular benefits of SGLT2i beyond glucose control, it is essential to better understand their effects on lipoproteins and their impact on cardiovascular disease.

Recent findings: SGLT2i have shown significant cardiovascular benefits in patients with type 2 diabetes mellitus, beyond their role in lowering blood glucose. Studies indicate that SGLT2i reduce major adverse cardiovascular events by impacting factors such as blood pressure, body weight, and arterial stiffness. However, their effects on lipid profile remain complex and somewhat inconsistent. Some research points to modest increases in LDL cholesterol, while others report shifts toward less atherogenic lipid profile, including reductions in triglycerides and small, dense LDL particles, and increases in HDL-C. SGLT2i represent a significant advancement in managing diabetes and associated cardiovascular risks, with benefits such as triglyceride reduction and HDL-C increase. While their impact on LDL-C remains controversial and varies across studies, the reduction of small, dense LDL particles may mitigate negative effects. This article highlights the need for future research to better understand the specific mechanisms behind lipid modulation.

综述目的:本文探讨了钠-葡萄糖共转运蛋白2抑制剂(SGLT2i)对2型糖尿病(T2DM)患者心血管的影响,特别关注了它们对血脂的影响。随着越来越多的证据表明SGLT2i在血糖控制之外对心血管的益处,有必要更好地了解它们对脂蛋白的影响及其对心血管疾病的影响。最近的研究发现:SGLT2i在2型糖尿病患者中显示出显著的心血管益处,而不仅仅是其降低血糖的作用。研究表明,SGLT2i通过影响血压、体重和动脉硬度等因素减少主要不良心血管事件。然而,它们对血脂的影响仍然复杂且有些不一致。一些研究指出低密度脂蛋白胆固醇有适度的增加,而另一些研究则报告了低密度脂蛋白的变化,包括甘油三酯和小而致密的低密度脂蛋白颗粒的减少,以及高密度脂蛋白c的增加。SGLT2i在管理糖尿病和相关心血管风险方面取得了重大进展,具有甘油三酯降低和HDL-C升高等益处。虽然它们对LDL- c的影响仍然存在争议,并且在不同的研究中存在差异,但减少小而致密的LDL颗粒可能会减轻负面影响。这篇文章强调了未来研究的需要,以更好地了解脂质调节背后的具体机制。
{"title":"Impact of SGLT2 Inhibitors on Lipoproteins in Type 2 Diabetes.","authors":"Pablo Corral, Natalia Nardelli, Alicia Elbert, Florencia Aranguren, Laura Schreier","doi":"10.1007/s11892-024-01572-0","DOIUrl":"10.1007/s11892-024-01572-0","url":null,"abstract":"<p><strong>Purpose of review: </strong>This article explores the cardiovascular effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes mellitus (T2DM), with a particular focus on their impact on lipid profiles. As evidence grows of the cardiovascular benefits of SGLT2i beyond glucose control, it is essential to better understand their effects on lipoproteins and their impact on cardiovascular disease.</p><p><strong>Recent findings: </strong>SGLT2i have shown significant cardiovascular benefits in patients with type 2 diabetes mellitus, beyond their role in lowering blood glucose. Studies indicate that SGLT2i reduce major adverse cardiovascular events by impacting factors such as blood pressure, body weight, and arterial stiffness. However, their effects on lipid profile remain complex and somewhat inconsistent. Some research points to modest increases in LDL cholesterol, while others report shifts toward less atherogenic lipid profile, including reductions in triglycerides and small, dense LDL particles, and increases in HDL-C. SGLT2i represent a significant advancement in managing diabetes and associated cardiovascular risks, with benefits such as triglyceride reduction and HDL-C increase. While their impact on LDL-C remains controversial and varies across studies, the reduction of small, dense LDL particles may mitigate negative effects. This article highlights the need for future research to better understand the specific mechanisms behind lipid modulation.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"25 1","pages":"16"},"PeriodicalIF":6.4,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142946113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inpatient Hypoglycemic Rate Reduction Through the Implementation of Prescriber Targeted Decision Support Tools. 通过实施处方者目标决策支持工具降低住院患者低血糖率。
IF 6.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-04 DOI: 10.1007/s11892-024-01571-1
Jessica Odom, Rebecca Goldstein

Purpose of review: Hypoglycemia has been shown to increase mortality and length of hospital stay and is now reportable to the Centers for Medicare and Medicaid Services as a quality measure. The purpose of this article is to review clinical decision support (CDS) tools designed to reduce inpatient hypoglycemic events.

Recent findings: CDS tools such as order set development, medication alerts, and data visibility have all been shown to be valuable tools in improving glycemic performance. This is especially true for hyperglycemic events with mixed results in hypoglycemia prevention. CDS solutions may be targeted directly to healthcare professionals or to specialty diabetes management teams to reduce hypoglycemia. Not all organizations have the financial resources to develop a diabetes management team so non-interruptive alerts may serve as an important tool to alert health care professionals of individuals with additional risk factors for the development of hypoglycemia. CDS can provide a mechanism to reduce the risk of hypoglycemia in hospitalized individuals. Although new research is promising, more studies are needed to determine future directions including the impact and feasibility of continuous glucose monitoring and predictive models to improve overall glycemic performance.

综述目的:低血糖已被证明会增加死亡率和住院时间,现在作为一项质量指标向医疗保险和医疗补助服务中心报告。本文的目的是回顾旨在减少住院低血糖事件的临床决策支持(CDS)工具。最近的发现:CDS工具,如订单集开发、药物警报和数据可见性,都被证明是改善血糖表现的有价值的工具。这尤其适用于高血糖事件,在预防低血糖方面效果不一。CDS解决方案可以直接针对医疗保健专业人员或专业糖尿病管理团队,以降低低血糖。并不是所有的组织都有足够的财力来组建糖尿病管理团队,因此,不间断警报可以作为一种重要的工具,提醒医疗保健专业人员注意有其他低血糖风险因素的个人。CDS可以提供一种降低住院患者低血糖风险的机制。虽然新的研究很有希望,但需要更多的研究来确定未来的方向,包括连续血糖监测和预测模型对改善整体血糖表现的影响和可行性。
{"title":"Inpatient Hypoglycemic Rate Reduction Through the Implementation of Prescriber Targeted Decision Support Tools.","authors":"Jessica Odom, Rebecca Goldstein","doi":"10.1007/s11892-024-01571-1","DOIUrl":"10.1007/s11892-024-01571-1","url":null,"abstract":"<p><strong>Purpose of review: </strong>Hypoglycemia has been shown to increase mortality and length of hospital stay and is now reportable to the Centers for Medicare and Medicaid Services as a quality measure. The purpose of this article is to review clinical decision support (CDS) tools designed to reduce inpatient hypoglycemic events.</p><p><strong>Recent findings: </strong>CDS tools such as order set development, medication alerts, and data visibility have all been shown to be valuable tools in improving glycemic performance. This is especially true for hyperglycemic events with mixed results in hypoglycemia prevention. CDS solutions may be targeted directly to healthcare professionals or to specialty diabetes management teams to reduce hypoglycemia. Not all organizations have the financial resources to develop a diabetes management team so non-interruptive alerts may serve as an important tool to alert health care professionals of individuals with additional risk factors for the development of hypoglycemia. CDS can provide a mechanism to reduce the risk of hypoglycemia in hospitalized individuals. Although new research is promising, more studies are needed to determine future directions including the impact and feasibility of continuous glucose monitoring and predictive models to improve overall glycemic performance.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"25 1","pages":"15"},"PeriodicalIF":6.4,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142926871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes Care Disparities in Deaf/Hard of Hearing and Blind/Low Vision Populations. 聋人/听力障碍和盲人/低视力人群的糖尿病护理差异
IF 6.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-30 DOI: 10.1007/s11892-024-01565-z
Allyson S Hughes, Karissa Mirus, Nazanin M Heydarian, Michelle L Litchman

Purpose of review: Describe the connection between Deaf/hard of hearing (DHH) and diabetes, explain the bidirectional relationship of blind/low vision (BLV) and diabetes, characterize challenges DHH and BLV populations face when seeking healthcare regarding their diabetes management. Highlight the inaccessibility of diabetes technology in these populations. Provide best practices when communicating with DHH and BLV people in the clinical setting.

Recent findings: Diabetes disparities exist in DHH and BLV populations due to systemic barriers to health equity related to access and communication. Structural barriers, risk factors, social determinants of health, and the U.S. healthcare system do not support the DHH and BLV communities. Importantly, healthcare professionals do not receive adequate training on communication and treatment of DHH and BLV populations. Together, social determinants of health, such as healthcare access and quality, education access and quality, and lack of adequate clinician training allow ableism to persist and drive health disparities in these communities. Health disparities faced by DHH and BLV populations are driven by barriers to diabetes standards of care. These inequities must be rectified to improve and maintain high quality care.

综述的目的:描述聋/听障(DHH)与糖尿病之间的联系,解释盲/低视力(BLV)与糖尿病的双向关系,描述DHH和BLV人群在寻求糖尿病管理方面的医疗保健时面临的挑战。强调这些人群难以获得糖尿病技术。在临床环境中与卫生部和BLV人员沟通时提供最佳实践。最近的发现:由于在获取和沟通方面存在卫生公平的系统性障碍,DHH和BLV人群中存在糖尿病差异。结构性障碍、风险因素、健康的社会决定因素和美国卫生保健系统不支持DHH和BLV社区。重要的是,卫生保健专业人员没有接受关于DHH和BLV人群的沟通和治疗的充分培训。保健机会和质量、教育机会和质量以及缺乏适当的临床医生培训等健康的社会决定因素加在一起,使残疾现象持续存在,并在这些社区造成健康差距。DHH和BLV人群面临的健康差异是由糖尿病护理标准的障碍造成的。必须纠正这些不公平现象,以改善和保持高质量的护理。
{"title":"Diabetes Care Disparities in Deaf/Hard of Hearing and Blind/Low Vision Populations.","authors":"Allyson S Hughes, Karissa Mirus, Nazanin M Heydarian, Michelle L Litchman","doi":"10.1007/s11892-024-01565-z","DOIUrl":"10.1007/s11892-024-01565-z","url":null,"abstract":"<p><strong>Purpose of review: </strong>Describe the connection between Deaf/hard of hearing (DHH) and diabetes, explain the bidirectional relationship of blind/low vision (BLV) and diabetes, characterize challenges DHH and BLV populations face when seeking healthcare regarding their diabetes management. Highlight the inaccessibility of diabetes technology in these populations. Provide best practices when communicating with DHH and BLV people in the clinical setting.</p><p><strong>Recent findings: </strong>Diabetes disparities exist in DHH and BLV populations due to systemic barriers to health equity related to access and communication. Structural barriers, risk factors, social determinants of health, and the U.S. healthcare system do not support the DHH and BLV communities. Importantly, healthcare professionals do not receive adequate training on communication and treatment of DHH and BLV populations. Together, social determinants of health, such as healthcare access and quality, education access and quality, and lack of adequate clinician training allow ableism to persist and drive health disparities in these communities. Health disparities faced by DHH and BLV populations are driven by barriers to diabetes standards of care. These inequities must be rectified to improve and maintain high quality care.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"25 1","pages":"14"},"PeriodicalIF":6.4,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11683019/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Gestational Diabetes on Kidney Development: is There an Epigenetic Link? 妊娠期糖尿病对肾脏发育的影响:是否存在表观遗传联系?
IF 6.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-18 DOI: 10.1007/s11892-024-01569-9
Giovane G Tortelote

Purpose of review: This review explores the mechanisms through which gestational diabetes mellitus GDM impacts fetal kidney development, focusing on epigenetic alterations as mediators of these effects. We examine the influence of GDM on nephrogenesis and kidney maturation, exploring how hyperglycemia-induced intrauterine stress can reduce nephron endowment and compromise renal function via dysregulation of normal epigenetic mechanisms.

Recent findings: In addition to metabolic impacts, emerging evidence suggests that GDM exerts its influence through epigenetic modifications, including DNA methylation, histone modifications, and non-coding RNA expression, which disrupt gene expression patterns critical for kidney development. Recently, specific epigenetic modifications observed in offspring exposed to GDM were implicated in aberrant activation or repression of genes essential for kidney development. Key pathways influenced by these epigenetic changes, such as oxidative stress response, inflammatory regulation, and metabolic pathways, are discussed to illustrate the broad molecular impact of GDM on renal development. Finally, we consider potential intervention strategies that could mitigate the adverse effects of GDM on kidney development. These include optimizing maternal glycemic control, dietary modifications, dietary supplementation, and pharmacological agents targeting epigenetic pathways. Through a comprehensive synthesis of current research, this review underscores the importance of early preventive strategies to reduce the burden of kidney disease in individuals exposed to GDM and highlights key epigenetic mechanisms altered during GDM that impact kidney development.

综述目的:本文探讨了妊娠期糖尿病(GDM)影响胎儿肾脏发育的机制,重点探讨了表观遗传改变作为这些影响的中介。我们研究了GDM对肾脏发生和肾脏成熟的影响,探讨了高血糖诱导的宫内应激如何通过正常表观遗传机制的失调来减少肾元供体和损害肾功能。最新发现:除了代谢影响外,新出现的证据表明,GDM通过表观遗传修饰施加影响,包括DNA甲基化、组蛋白修饰和非编码RNA表达,这些修饰会破坏对肾脏发育至关重要的基因表达模式。最近,在暴露于GDM的后代中观察到的特定表观遗传修饰与肾脏发育必需基因的异常激活或抑制有关。本文讨论了受这些表观遗传变化影响的关键途径,如氧化应激反应、炎症调节和代谢途径,以说明GDM对肾脏发育的广泛分子影响。最后,我们考虑了可能减轻GDM对肾脏发育不利影响的潜在干预策略。这些措施包括优化产妇血糖控制、饮食调整、膳食补充和针对表观遗传途径的药理学药物。通过对当前研究的全面综合,本综述强调了早期预防策略对减轻GDM暴露个体肾脏疾病负担的重要性,并强调了GDM期间影响肾脏发育的关键表观遗传机制的改变。
{"title":"The Impact of Gestational Diabetes on Kidney Development: is There an Epigenetic Link?","authors":"Giovane G Tortelote","doi":"10.1007/s11892-024-01569-9","DOIUrl":"10.1007/s11892-024-01569-9","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review explores the mechanisms through which gestational diabetes mellitus GDM impacts fetal kidney development, focusing on epigenetic alterations as mediators of these effects. We examine the influence of GDM on nephrogenesis and kidney maturation, exploring how hyperglycemia-induced intrauterine stress can reduce nephron endowment and compromise renal function via dysregulation of normal epigenetic mechanisms.</p><p><strong>Recent findings: </strong>In addition to metabolic impacts, emerging evidence suggests that GDM exerts its influence through epigenetic modifications, including DNA methylation, histone modifications, and non-coding RNA expression, which disrupt gene expression patterns critical for kidney development. Recently, specific epigenetic modifications observed in offspring exposed to GDM were implicated in aberrant activation or repression of genes essential for kidney development. Key pathways influenced by these epigenetic changes, such as oxidative stress response, inflammatory regulation, and metabolic pathways, are discussed to illustrate the broad molecular impact of GDM on renal development. Finally, we consider potential intervention strategies that could mitigate the adverse effects of GDM on kidney development. These include optimizing maternal glycemic control, dietary modifications, dietary supplementation, and pharmacological agents targeting epigenetic pathways. Through a comprehensive synthesis of current research, this review underscores the importance of early preventive strategies to reduce the burden of kidney disease in individuals exposed to GDM and highlights key epigenetic mechanisms altered during GDM that impact kidney development.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"25 1","pages":"13"},"PeriodicalIF":6.4,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11652566/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142845969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parental Psychosocial Variables and Glycemic Control in T1D Pediatric Age: A Systematic Review. 父母的社会心理变量与 T1D 儿童的血糖控制:系统综述。
IF 6.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-16 DOI: 10.1007/s11892-024-01566-y
Vasco Costa, Bárbara Pereira, Susana R Patton, Tânia Brandão

Purpose of review: This review aimed to summarize the evidence regarding the relationship between parental psychosocial (e.g., fear of hypoglycemia, stress and family conflict) and glycemic outcomes in children between the age of 1-10 years old.

Recent findings: Type 1 Diabetes (T1D) in young children can be very complex to manage for their parents since they are the main individuals responsible for T1D tasks. Also, parental psychological adjustment impacts children's glycemic outcomes. This systematic review was performed following the PRISMA guidelines. The search process was conducted in four databases from 2019 to 2024. From a total of 215 studies, 5 were included. We identified five studies that found direct associations between parental psychosocial variables and children's glycemic outcomes. These findings suggest a unidirectional perspective, evidencing the need to examine the longitudinal interplay between these variables. In sum, promoting parental psychological interventions may be fundamental for enhancing children's glycemic outcomes.

综述目的:本综述旨在总结1-10岁儿童的父母心理社会(如对低血糖的恐惧、压力和家庭冲突)与血糖结局之间关系的证据。最近的研究发现:幼儿的1型糖尿病(T1D)对于父母来说可能非常复杂,因为他们是负责T1D任务的主要个体。此外,父母的心理调整也会影响孩子的血糖结局。该系统评价遵循PRISMA指南进行。从2019年到2024年,在四个数据库中进行了搜索。从215项研究中,有5项被纳入。我们确定了五项研究,发现父母心理社会变量与儿童血糖结局之间存在直接关联。这些发现提出了一个单向的观点,证明需要检查这些变量之间的纵向相互作用。总之,促进父母心理干预可能是提高儿童血糖结局的基础。
{"title":"Parental Psychosocial Variables and Glycemic Control in T1D Pediatric Age: A Systematic Review.","authors":"Vasco Costa, Bárbara Pereira, Susana R Patton, Tânia Brandão","doi":"10.1007/s11892-024-01566-y","DOIUrl":"10.1007/s11892-024-01566-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review aimed to summarize the evidence regarding the relationship between parental psychosocial (e.g., fear of hypoglycemia, stress and family conflict) and glycemic outcomes in children between the age of 1-10 years old.</p><p><strong>Recent findings: </strong>Type 1 Diabetes (T1D) in young children can be very complex to manage for their parents since they are the main individuals responsible for T1D tasks. Also, parental psychological adjustment impacts children's glycemic outcomes. This systematic review was performed following the PRISMA guidelines. The search process was conducted in four databases from 2019 to 2024. From a total of 215 studies, 5 were included. We identified five studies that found direct associations between parental psychosocial variables and children's glycemic outcomes. These findings suggest a unidirectional perspective, evidencing the need to examine the longitudinal interplay between these variables. In sum, promoting parental psychological interventions may be fundamental for enhancing children's glycemic outcomes.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"25 1","pages":"11"},"PeriodicalIF":6.4,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649725/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142827731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Diabetes Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1